Ozempic 0.25ng is a once-weekly injectable medication used in the treatment of type 2 diabetes. It belongs to a class of drugs known as GLP-1 receptor agonists, which work by stimulating insulin production in response to elevated blood sugar levels, as well as suppressing glucagon secretion to help lower blood sugar levels. Clinical studies have shown that Ozempic can significantly reduce A1C levels and body weight when used as part of a comprehensive diabetes management plan that includes diet and exercise. The most common side effects of Ozempic include nausea, vomiting, diarrhea, and abdominal pain, but these typically subside over time. It is important for healthcare professionals to monitor patients regularly while on this medication to ensure any potential adverse effects are caught early and managed appropriately.